Drugs / Lymphocytes, Activated
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00000756 | ? → Jun 2002 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT00000875 | ? → Apr 2003 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
| — | NCT00000824 | ? → Jun 2005 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lymphocytes, Activated | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000756 ↗ |
| Known as | CTLs | “autologous cytotoxic T-lymphocytes (CTLs)” NCT00000756 ↗ |
| Action | Deplete | “frequently lyse autologous HIV-1-expressing cells” NCT00000756 ↗ |
| Modality | Cell therapy | “adoptive immunotherapy with autologous cytotoxic T-lymphocytes (CTLs)” NCT00000756 ↗ |